Pyoderma Gangrenosum: An Update

Rheumatic Disease Clinics of North America

Volumn 33, Issue 4, 2007, Pages 787-802

  Callen, Jeffrey P ^a   Jackson, J Mark ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CHLORAMBUCIL; COLCHICINE; CROMOGLYCATE DISODIUM; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; DOXYCYCLINE; ETANERCEPT; GLUCOCORTICOID; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; MINOCYCLINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICOTINE; PETROLATUM; PIMECROLIMUS; PREDNISONE; SULFAPYRIDINE; TACROLIMUS; THALIDOMIDE;

ARTHRITIS; BURULI ULCER; CARCINOMA; CATARACT; CELLULITIS; CLINICAL TRIAL; CORTICOSTEROID INDUCED OSTEOPOROSIS; CROHN DISEASE; DERMATITIS HERPETIFORMIS; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ENTERITIS; FRACTURE; HUMAN; IMMUNOMODULATION; INFECTION RISK; INJURY; LEISHMANIASIS; LEUKEMIA; MULTIPLE CYCLE TREATMENT; MYCOBACTERIOSIS; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; REVIEW; SIDE EFFECT; SKIN BIOPSY; SKIN DISEASE; SKIN LYMPHOMA; SKIN TUBERCULOSIS; SPOROTRICHOSIS; SQUAMOUS CELL CARCINOMA; THROMBOPHILIA; WOUND DRESSING;

DIAGNOSIS, DIFFERENTIAL; HUMANS; PROGNOSIS; PYODERMA GANGRENOSUM;

EID: 36249026426     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2007.07.016     Document Type: Review

References (78)

1. Brunsting L.A., Goeckerman W.H., and O'Leary P.A. Pyoderma gangrenosum: clinical and experimental observations in five cases occurring in adults. Arch Derm Syphilol 22 (1930) 655-680
2. Adachi Y., Kindzelskii A.L., Cookingham G., et al. Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosum. J Invest Dermatol 111 (1998) 259-268
3. Takeuchi K., Kyoko H., Hachiya M., et al. Pyoderma gangrenosum of the skin and respiratory tract in a 5 year-old girl. Eur J Pediatr 162 (2003) 344-345
4. Torrelo A., Colmenero I., Serrano C., et al. Pyoderma gangrenosum in an infant. Pediatr Dermatol 23 (2006) 338-341
5. Callen J.P. Pyoderma gangrenosum. Lancet 351 (1998) 581-585
6. Jackson J.M., and Callen J.P. Pyoderma gangrenosum: an expert commentary. Expert Rev Dermatol 1 (2006) 391-400
7. Brooklyn T., Dunnill G., and Robert C. Diagnosis and treatment of pyoderma gangrenosum. BMJ 333 (2006) 181-184
8. Powell F.C., and Collins S. Pyoderma gangrenosum. Clin Dermatol 18 (2000) 283-293
9. Vidal D., Puig L., Gilaberte M., et al. Review of 26 cases of classical pyoderma gangrenosum: clinical and therapeutic features. J Dermatolog Treat 15 (2004) 146-152
10. Bennett M.L., Jackson J.M., Jorizzo J.L., et al. Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine 79 (2000) 37-46
11. Charles C.A., Bialy T.L., Falabella A.F., et al. Poor prognosis of arthritis-associated pyoderma gangrenosum. Arch Dermatol 140 (2004) 861-864
12. Shankar S., Sterling J.C., and Rytina E. Pustular pyoderma gangrenosum. Clin Exp Dermatol 28 (2003) 600-603
13. Walling H.W., Snipes C.J., Gerami P., et al. The relationship between neutrophilic dermatosis of the dorsal hands and Sweet syndrome: report of 9 cases and comparison to atypical pyoderma gangrenosum. Arch Dermatol 142 (2006) 57-63
14. Louis D.S., and Jebson P.J. Mimickers of hand infections. Hand Clin 4 (1998) 519-529
15. Huish S.B., de La Paz E.M., Ellis P.R., et al. Pyoderma gangrenosum of the hand: a case series and review of the literature. J Hand Surg Am 26 (2001) 679-685
16. Isomura I., Miyawaki S., and Morita A. Pyoderma gangrenosum associated with nasal septal perforation, oropharyngeal ulcers and IgA paraproteinemia. J Dermatol 32 (2005) 193-198
17. Jackson J.M., and Callen J.P. Pyoderma gangrenosum and IgA myeloma. J Cutan Med Surg 2 (1997) 100-103
18. Hughes A.P., Jackson J.M., and Callen J.P. Clinical features and treatment of peristomal pyoderma gangrenosum. JAMA 284 (2000) 1546-1548
19. Lally A., Hollowood K., Bunker C.B., et al. Penile pyoderma gangrenosum treated with topical tacrolimus. Arch Dermatol 141 (2005) 1175-1176
20. Hernandez-Martin A., Arias-Paloma D., Hermida G., et al. Oral pyoderma gangrenosum. Br J Dermatol 149 (2003) 663-664
21. Setterfield J.F., Shirlaw P.J., Challacombe S.J., et al. Pyoderma gangrenosum associated with severe oropharyngeal involvement and IgA paraproteinemia. Br J Dermatol 144 (2001) 393-396
22. Lachapelle J.M., Marot L., and Jablonska S. Superficial granulomatous pyoderma gangrenosum of the face successfully treated by cyclosporin: a long-term follow-up. Dermatology 202 (2001) 155-157
23. Banga F., Schuitemaker N., and Meijer P. Pyoderma gangrenosum after caesarean section: a case report. Reprod Health 3 (2006) 1-5
24. Brown T.S., Marshall G.S., and Callen J.P. Cavitating pulmonary infiltrate in an adolescent with pyoderma gangrenosum: a rarely recognized extracutaneous manifestation of a neutrophilic dermatosis. J Am Acad Dermatol 43 (2000) 108-112
25. Yoshida C., Kojima H., Shigaki T., et al. Association of pyoderma gangrenosum and sterile osteomyelitis in a patient having myelodysplastic syndrome. Eur J Heamatol 72 (2004) 149-153
26. Nurre L.D., Rabalais G.P., and Callen J.P. Neutrophilic dermatosis-associated sterile chronic multifocal osteomyelitis in pediatric patients: case report and review. Pediatr Dermatol 16 (1999) 214-216
27. Wilson D.M., John G.R., and Callen J.P. Peripheral ulcerative keratitis- an extracutaneous neutrophilic disorder: report of a patient with rheumatoid arthritis, pustular vasculitis, pyoderma gangrenosum, and Sweet's syndrome with an excellent response to cyclosporine therapy. J Am Acad Dermatol 40 (1999) 331-334
28. Vadillo M., Jucgla A., Podzamczer D., et al. Pyoderma gangrenosum with liver, spleen, and bone involvement in a patient with chronic myelomonocytic leukemia. Br J Dermatol 141 (1999) 541-543
29. Muster A.J., Bhaarati S., Herman J.J., et al. Fatal cardiovascular disease and cutis laxa following acute febrile neutrophilic dermatosis. J Pediatr 102 (1983) 243-248
30. Marie I., Levesque H., Joly P., et al. Neutrophilic myositis as an extracutaneous manifestation of neutrophilic dermatosis. J Am Acad Dermatol 44 1 (2001) 137-139 2001
31. Vignon-Pennamen M.D. The extracutaneous involvement in the neutrophilic dermatoses. Clin Dermatol 18 3 (2000) 339-347
32. Trent J.T., and Kirsner R.S. Diagnosing pyoderma gangrenosum. Adv Skin Wound Care 14 (2001) 151-153
33. Schmid M.H., Hary C., Marstaller B., et al. Pyoderma gangrenosum associated with secondary antiphospholipid syndrome. Eur J Dermatol 1 (1998) 45-47
34. Smith J.B., Shenefelt P.D., Soto O., et al. Pyoderma gangrenosum in a patient with cryoglobulinemia and hepatitis C successfully treated with interferon alfa. J Am Acad Dermatol 34 (1996) 901-903
35. Barrio V.R., Sanfilippo A.M., Malone J.C., et al. Nonhealing ulcer secondary to factor V Leiden mutation and cryofibrinogenemia. J Am Acad Dermatol 51 Suppl 5 (2004) S194-S196
36. Byrd D.R., El-Azhary R.A., Gibson L.E., et al. Sporotrichosis masquerading as pyoderma gangrenosum: case report and review of 19 cases of sporotrichosis. J Eur Acad Dermatol Venereol 15 (2001) 581-584
37. Laochumroonvorapong P., DiCostanzo D.R., Wu H., et al. Disseminated histoplasmosis presenting as pyoderma gangrenosum-like lesions in a patient with acquired immunodeficiency syndrome. Int J Dermatol 40 (2001) 518-521
38. Yang C.C., Hsieh F.S., and Lee J.Y. Pyoderma gangrenosum complicated by ecthyma gangrenosum. Br J Dermatol 150 (2004) 1025-1026
39. Oh C.C., McKenna D.B., McLaren K.M., et al. Factitious panniculitis masquerading as pyoderma gangrenosum. Clin and Exp Dermatol 30 (2005) 253-255
40. Weenig R.H., Davis M.D., Dahl P.R., et al. Skin ulcers misdiagnosed as pyoderma gangrenosum. N Engl J Med 347 18 (2002) 1412-1418
41. Su W.P.D., Davis M.D., Weenig R.H., et al. Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria. Int J Dermatol 43 (2004) 790-800
42. Malone J.C., Slone S.P., Wills-Frank L.A., et al. Vascular inflammation (vasculitis) in Sweet syndrome: a clinicopathologic study of 28 biopsy specimens from 21 patients. Arch Dermatol 138 3 (2002) 345-349
43. Farina M.C., Requena L., Domine M., et al. Histopathology of cutaneous reaction to granulocyte colony-stimulating factor: another pseudomalignancy. J Cutan Pathol 25 10 (1998) 559-562
44. Brown T.S., and Callen J.P. Atypical presentation of herpes simplex virus in a patient with chronic lymphocytic leukemia. Cutis 64 2 (1999) 123-125
45. Gettler S., Rothe M., Grin C., et al. Optimal treatment of pyoderma gangrenosum. Am J Clin Dermatol 4 (2003) 597-608
46. Powell F.C., and O'Kane M. Management of pyoderma gangrenosum. Dermatol Clin 20 (2002) 347-355
47. de Imus G., Golomb C., Wilkel C., et al. Accelerated healing of pyoderma gangrenosum treated with bioengineered skin and concomitant immunosuppression. J Am Acad Dermatol 44 (2001) 61-66
48. Chiba T., Isomura I., Suzuki A., et al. Topical tacrolimus therapy for pyoderma gangrenosum. J Dermatol 32 (2005) 199-203
49. Vidal D., and Alomar A. Successful treatment of peristomal pyoderma gangrenosum using topical tacrolimus. Br J Dermatol 150 (2004) 387-388
50. Nybaek H., Olsen A.G., Karlsmark T., et al. Topical therapy for peristomal pyoderma gangrenosum. J Cutan Med Surg 8 (2004) 220-223
51. Patel G.K., Thodes J.R., Evans B., et al. Successful treatment of pyoderma gangrenosum with topical 0.5% nicotine cream. J Dermatolog Treat 15 (2004) 122-125
52. Langenbach N., Goetz A., Hohenleutner U., et al. Effectiveness of 4% disodium cromoglycate in the treatment of disseminated pyoderma gangrenosum. Acta Derm Venereol 76 (1996) 501-502
53. Zakhireh M., Rockwell W.B., and Fryer R.H. Stabilization of pyoderma gangrenosum ulcer with oral cyclosporine prior to skin grafting. Plast Reconstr Surg 113 (2004) 1417-1420
54. Patrone P., Bragadin G., De Francesco V., et al. Pyoderma gangrenosum of the scalp treated with cyclopsorine A. Int J Dermatol 41 (2002) 916-918
55. Schofer H., and Baur S. Successful treatment of postoperative pyoderma gangrenosum with cyclosporin. J Eur Acad Dermatol Venereol 16 (2002) 148-151
56. Daniels N.H., and Callen J.P. Mycophenolate mofetil is an effective treatment for peristomal pyoderma gangrenosum. Arch Dermatol 140 (2004) 1427-1429
57. Lee M.R., and Cooper A.J. Mycophenolate mofetil in pyoderma gangrenosum. J Dermatolog Treat 15 (2004) 303-307
58. Nousari H.C., Lynch W., Anhalt G.J., et al. The effectiveness of mycophenolate mofetil in refractory pyoderma gangrenosum. Arch Dermatol 134 (1998) 1509-1511
59. Teitel A.D. Treatment of pyoderma gangrenosum with methotrexate. Cutis 57 (1996) 326-328
60. Burruss J.B., Farmer E.R., and Callen J.P. Chlorambucil is an effective corticosteroid-sparing agent for recalcitrant pyoderma gangrenosum. J Am Acad Dermatol 5 (1996) 720-724
61. Federman G.L., and Federman D.G. Recalcitrant pyoderma gangrenosum treated with thalidomide. Mayo Clin Proc 75 (2000) 842-844
62. Kontochristopoulos G.J., Stavropoulos P.G., Gregoriou S., et al. Treatment of pyoderma gangrenosum with low-dose colchicine. Dermatology 209 (2004) 233-236
63. Reynoso-von Drateln C., Perla-Navarro A.V., Gamez-Nava J.I., et al. Intravenous cyclophosphamide pulses in pyoderma gangrenosum: an open trial. J Rheumatol 24 (1997) 689-693
64. Fox L.P., and Pandya A.G. Pulse intravenous cyclophosphamide therapy for dermatologic disorders. Dermatol Clin 18 3 (2000) 459-473
65. Shenefelt P.D. Pyoderma gangrenosum associated with cystic acne and hidradenitis suppurativa controlled by adding minocycline and sulfasalazine to the treatment regimen. Cutis 57 (1996) 315-319
66. Mcgowan J.W., Johnson C.A., and Lynn A. Treatment of pyoderma gangrenosum with etanercept. J Drugs Dermatol 3 (2004) 441-444
67. Jenne L., Sauter B., Thurmann P., et al. Successful treatment of therapy-resistant chronic vegetating pyoderma gangrenosum with infliximab. Br J Dermatol 150 (2004) 380-382
68. Mimouni D., Anhalt G.J., Kouba D.J., et al. Infliximab for peristomal pyoderma gangrenosum. Br J Dermatol 148 (2003) 813-816
69. Stichweh D.S., Punaro M., and Pascual V. Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome. Pediatr Dermatol 22 (2005) 262-265
70. Bens G., Laharie D., Beylot-Barry M., et al. Successful treatment with infliximab and methotrexate of pyostomatitis vegetans associated with Crohn's disease. Br J Dermatol 149 1 (2003) 181-184
71. Brooklyn T.N., Dunnill G.S., Shetty A., et al. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double-blind placebo-controlled trial. Gut 55 (2006) 505-509
72. Hewitt D., and Tan C. Use of infliximab in pyoderma gangrenosum. Australas J Dermatol 48 (2007) 95-98
73. Kouklakis G., Moschos J., Leontiadis G.I., et al. Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease: a case report. Rom J Gastroenterol 14 (2005) 401-403
74. Rispo A., Scarpa R., Di Girolamo E., et al. Infliximab in the treatment of extra-intestinal manifestations of Crohn's disease. Scand J Rheumatol 34 (2005) 387-391
75. Hubbard V.G., Friedmann A.C., and Goldsmith P. Systemic pyoderma gangrenosum responding to infliximab and adalimumab. Br J Dermatol 152 (2005) 1059-1061
76. Hagman J.H., Carrozzo A.M., Campione E., et al. The use of high-dose immunoglobulin in the treatment of pyoderma gangrenosum. J Dermatolog Treat 12 (2001) 19-22
77. Dirschka T., Kastner U., Behrens S., et al. Successful treatment of pyoderma gangrenosum with intravenous human immunoglobulin. J Am Acad Dermatol 39 (1998) 789-790
78. Zhang X., He Y., Zhou H., et al. A case of pyoderma gangrenosum responding to high-dose intravenous immunoglobulin therapy. Chin Med J 119 (2006) 1230-1232